<?xml version="1.0" encoding="UTF-8"?>
<p>Endometriosis is very challenging to treat. The management of endometriosis could be surgical or conservative [
 <xref rid="B15-plants-10-00587" ref-type="bibr">15</xref>]. The most commonly used therapeutic agents are nonsteroidal anti-inflammatory drugs (NSAID) and hormonal medication for repressing the ovarian function, such as oral contraceptives, gonadotropin-releasing hormone (GnRH) agonists, selective progesterone receptor modulators, androgens, or aromatase inhibitors [
 <xref rid="B16-plants-10-00587" ref-type="bibr">16</xref>]. Aromatase inhibitors, GnRH antagonists, anti-tumor necrosis factor- α (TNF-α), antiangiogenic factors and selective progesterone receptor modulators are the newest medical therapies for endometriosis [
 <xref rid="B17-plants-10-00587" ref-type="bibr">17</xref>]. These hormonal treatments have various side effects and usually they are not fully effective [
 <xref rid="B18-plants-10-00587" ref-type="bibr">18</xref>]. In addition to the drug therapy, the surgical resection is used in order to remove the detectable ectopic sites of endometriosis, leading to improved fertility, and complete or partial pain relief. However, the reoccurrence of the endometriotic lesions is still possible [
 <xref rid="B19-plants-10-00587" ref-type="bibr">19</xref>].
</p>
